Why the study?
Current imaging technology allows for more comprehensive assessment of pulmonary hypertension beyond basic measurements, with the potential to improve risk stratification and guide therapy.
Novel cardiovascular imaging techniques, including advanced echocardiography and MRI, offer comprehensive assessment of pulmonary hypertension, potentially enhancing risk stratification and therapeutic approaches.
Advanced imaging may refine PH risk stratification; leaves open whether it alters therapy pending validation.
Cardiovascular imaging is essential in the evaluation and management of patients with pulmonary hypertension. Echocardiography and magnetic resonance imaging, in particular, provide basic measurements of pulmonary pressure and right ventricular function, but current technology allows for a much more comprehensive assessment. Many of these advancements have the potential to enhance risk stratification and provide additional phenotypic data that may strengthen or alter the therapeutic approach. This review will highlight multiple novel techniques from various imaging modalities and how this information can be applied in clinical practice.
No takes yet. Share an insight, caveat, or question.
Narang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: